SCHEMBL1770105

SCHEMBL1770105

CSc1nnc(SCC(=O)C23CC4CC(CC(C4)C2)C3)s1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 3/20 0.78
▸ NPC1 O15118 3/20 0.56
▸ RAB9A P51151 2/20 0.56
▸ NTSR1 P30989 1/20 0.56
▸ ALDH1A1 P00352 6/20 0.53
▸ LMNA P02545 3/20 0.48
▸ HTT P42858 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ MAPT P10636 1/20 0.48
▸ STAT6 P42226 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ HIF1A Q16665 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ PTGES O14684 1/20 0.44
▸ GAA P10253 2/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ TP53 P04637 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1770040 0.87 HSD11B1 (1.00) HSD11B1NPC1RAB9AALDH1A1HTT
SCHEMBL1769899 0.83 HSD11B1 (0.73) HSD11B1NPC1RAB9AALDH1A1LMNA
SCHEMBL1770139 0.83 HSD11B1 (0.72) HSD11B1NPC1RAB9ANTSR1ALDH1A1
SCHEMBL1770128 0.81 HSD11B1 (0.69) HSD11B1NPC1RAB9ANTSR1ALDH1A1
SCHEMBL1770047 0.77 HSD11B1 (0.64) HSD11B1NPC1RAB9ANTSR1ALDH1A1
SCHEMBL14557231 0.72 GAA (0.68) ALDH1A1MEN1MAPTKMT2ASMN1; SMN2
SCHEMBL11855394 0.71 HSD11B1 (0.51) HSD11B1ALDH1A1LMNAHTTMEN1
SCHEMBL6084790 0.70 POLB (0.61) HSD11B1NPC1RAB9AALDH1A1LMNA
SCHEMBL1770455 0.69 HSD11B1 (0.64) HSD11B1ALDH1A1LMNAHTTMEN1
SCHEMBL6085750 0.69 ALDH1A1 (0.58) HSD11B1ALDH1A1LMNAHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110112151-A1 COMPOUND CAPABLE OF INHIBITING 11-BETA HYDROXYSTERIOD DEHYDROGENASE STERIX LIMITED (GB) 2011-05-12 — — US disclosed
US-20110112151-A1 COMPOUND CAPABLE OF INHIBITING 11-BETA HYDROXYSTERIOD DEHYDROGENASE STERIX LIMITED (GB) 2011-05-12 — — US disclosed
US-20110112151-A1 COMPOUND CAPABLE OF INHIBITING 11-BETA HYDROXYSTERIOD DEHYDROGENASE STERIX LIMITED (GB) 2011-05-12 — — US disclosed
EP-2257528-A2 1 IBETA-HYDROXYSTEROID DEHYDROGENASE INHIBITORS Sterix Limited (GB) 2010-12-08 — — EP disclosed
WO-2009106817-A2 COMPOUND STERIX LIMITED (GB) 2009-09-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112151-A1 COMPOUND CAPABLE OF INHIBITING 11-BETA HYDROXYSTERIOD DEHYDROGENASE HSD11B1, HSD11B2, HSD3B1 HSD11B1 1/4885NPC1 1692/4885RAB9A 3505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback